TickerFacts.

Mira Pharmaceuticals, Inc. (MIRA): Cash & Equivalents

Annual figures by period end, from SEC filings.

$6.35M
As of 2025-12-31
$3.61M
As of 2026-06-30
2024-12-31: $2.83M2025-12-31: $6.35M$6.35M
2024-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$6.35M+124.0%2026-03-31, Balance as of period end
2024-12-31$2.83Mn/a2026-03-31, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Mira Pharmaceuticals, Inc. (MIRA)2025-12-31$6.35M+124.0%
MetaVia Inc. (MTVA)2025-12-31$10.28M-35.8%
Decoy Therapeutics Inc. (DCOY)2025-12-31$10.71M+339.9%
Lantern Pharma Inc. (LTRN)2025-12-31$4.42M-41.1%
NewcelX Ltd. (NCEL)2025-12-31$2.20M+238.6%
Curanex Pharmaceuticals Inc (CURX)2025-12-31$5.00Mn/a
Revelation Biosciences, Inc. (REVB)2025-12-31$10.70M+64.6%
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)2025-12-31$334.0K-82.6%
Longeveron Inc. (LGVN)2025-12-31$4.66M-75.8%

Compare MIRA, MTVA, DCOY, LTRN side by side · Screen every company in Pharmaceutical Preparations ↗